Medicare Enrolled
Dr. Ken Haberman, MD
Urology Physician · Federal Way, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Haberman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Haberman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Haberman
Dr. Ken Haberman is an urology physician in Federal Way, WA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Haberman performed 3,024 Medicare services across 2,012 unique beneficiaries.
Between the years covered by Open Payments, Dr. Haberman received a total of $28,352 from 63 pharmaceutical and/or device companies across 332 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Haberman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 20% volume in WA
$28,352 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,024
Medicare services
Top 20% in WA for urology physician
2,012
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~168 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
558 | $98 | $200 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
505 | $2 | $15 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
324 | $9 | $50 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
270 | $8 | $15 |
| PSA test (prostate cancer screening) | 258 | $18 | $50 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
209 | $3 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
156 | $73 | $135 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 137 | $132 | $629 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
131 | $148 | $239 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
114 | $11 | $150 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
83 | $19 | $50 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
73 | $216 | $395 |
| New patient office visit, complex (60-74 min) | 46 | $181 | $375 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
42 | $31 | $50 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
33 | $52 | $135 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
23 | $121 | $200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
21 | $150 | $362 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
16 | $44 | $175 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
14 | $187 | $420 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $127 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$28,352
Total received (2018-2024)
Avg $4,050/year across 7 years
Top 5% in WA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
332
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$21,125 (74.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,011 (24.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$216 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$11,869
2023
$12,064
2022
$856
2021
$656
2020
$199
2019
$1,603
2018
$1,105
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Verathon Inc.
$10,225
Dendreon Pharmaceuticals LLC
$305
Ferring Pharmaceuticals Inc.
$170
ABBVIE INC.
$153
Myriad Genetic Laboratories, Inc.
$123
Janssen Biotech, Inc.
$99
IMMUNITYBIO, INC.
$88
Astellas Pharma US Inc
$87
ConvaTec Inc.
$77
Sumitomo Pharma America, Inc.
$75
Merck Sharp & Dohme LLC
$70
Bayer Healthcare Pharmaceuticals Inc.
$64
PROGENICS PHARMACEUTICALS, INC.
$63
Blue Earth Diagnostics Limited
$53
Endo USA, Inc.
$43
C. R. Bard, Inc. & Subsidiaries
$42
ACCORD HEALTHCARE, INC.
$39
Novartis Pharmaceuticals Corporation
$35
AngioDynamics, Inc.
$30
UROGEN PHARMA, INC.
$29
Top 3 companies account for 90.2% of 2024 payments
All-time payments by company (2018-2024) ›
Verathon Inc.
$21,125
Astellas Pharma US Inc
$805
Janssen Biotech, Inc.
$670
Dendreon Pharmaceuticals LLC
$597
Myriad Genetic Laboratories, Inc.
$475
Boston Scientific Corporation
$404
PFIZER INC.
$329
Bayer HealthCare Pharmaceuticals Inc.
$300
Coloplast Corp
$281
Ferring Pharmaceuticals Inc.
$267
Endo Pharmaceuticals Inc.
$155
ABBVIE INC.
$153
Myovant Sciences Inc.
$148
Osiris Therapeutics Inc.
$120
Rochester Medical Corporation
$117
Bayer Healthcare Pharmaceuticals Inc.
$108
Antares Pharma, Inc.
$105
Sumitomo Pharma America, Inc.
$101
UROVANT SCIENCES INC
$89
TOLMAR Pharmaceuticals, Inc.
$89
IMMUNITYBIO, INC.
$88
AstraZeneca Pharmaceuticals LP
$85
Merck Sharp & Dohme LLC
$82
MEDIVATION FIELD SOLUTIONS LLC
$79
ConvaTec Inc.
$77
Sun Pharmaceutical Industries Inc.
$74
180 Medical, Inc.
$71
C. R. Bard, Inc. & Subsidiaries
$70
UroGen Pharma, Inc.
$68
AbbVie Inc.
$67
ACCORD HEALTHCARE, INC.
$65
PROGENICS PHARMACEUTICALS, INC.
$63
AbbVie, Inc.
$60
Progenics Pharmaceuticals, Inc.
$58
Novartis Pharmaceuticals Corporation
$58
UROGEN PHARMA, INC.
$55
Allergan Inc.
$55
Blue Earth Diagnostics Limited
$53
Mallinckrodt LLC
$47
Avadel Specialty Pharmaceuticals, LLC
$46
Amgen Inc.
$44
Endo USA, Inc.
$43
C. R. BARD, INC. & SUBSIDIARIES
$41
Smith+Nephew, Inc.
$40
TherapeuticsMD, Inc.
$37
Allergan, Inc.
$36
AngioDynamics, Inc.
$30
BOSTON SCIENTIFIC CORPORATION
$30
Telix Pharmaceuticals
$29
Tolmar, Inc.
$28
Ethicon US, LLC
$27
Hollister Incorporated
$26
Augmenix, Inc.
$23
Medtronic USA, Inc.
$22
Laborie Medical Technologies Corp.
$21
DENTSPLY IH Inc.
$21
PALETTE LIFE SCIENCES, INC.
$20
Olympus America Inc.
$19
Profound Medical Corp.
$16
COLOPLAST CORP
$12
Mission Pharmacal Company
$12
UroMed, Inc.
$11
Amniox Medical, Inc.
$10
Top 3 companies account for 79.7% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS · ANKTIVA · AVEED · Advantage System · BOTOX · BRACAnalysis CDx · Bard Urinary Drainage Bag · CAMCEVI · ELIGARD · ERLEADA · Erleada · FASLODEX · FIRMAGON · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL THERAPIES · GENERAL ERECTILE DYSFUNCTION · GENTLECATH GLIDE · General - Vascular Access · ILLUCCIX · IMVEXXY · INTERSTIM · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NANOKNIFE · NEOX · NOCDURNA · NPD Clinical Study · Noctiva · Non-Covered · Nubeqa · OFIRMEV · ORGOVYX · Otrexup · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · Prolia · SOLYX · SPEEDICATH · STRAVIX · SpaceOAR · SpeediCath · Stravix · TOVIAZ · Tulsa-Pro · Uribel · VISTASEAL · VaPro · VaPro Pocket · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (74%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for urology physician in WA.
Geographic Context
Urology physicians within 10 mi
159
Per 100K population
7.0
County median income
$122,148
Nearest hospital
ST FRANCIS COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Haberman is a clinical cardiology specialist, with above-average Medicare volume (top 20% in WA), with consulting-driven industry engagement in the top 5% of WA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Haberman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Haberman performed 558 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Haberman receive payments from pharmaceutical companies?
Yes. Dr. Haberman received a total of $28,352 from 63 companies across 332 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Haberman's costs compare to other urology physicians in Federal Way?
Dr. Haberman's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Haberman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Federal Way
Browse urology physicians in Federal Way ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in WA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in WA
Which WA urology physicians receive the most from drug and device companies.
By company
Verathon Inc. Payments to Doctors
See all physicians who received payments from Verathon Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology